Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.170
+0.020 (1.74%)
Jul 31, 2026, 4:08 PM HKT

Cloudbreak Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.250.2510.210.880.47
Revenue Growth
-97.53%-97.52%1060.68%86.84%-
Gross Profit
0.250.2510.210.880.47
Operating Income
-107.18-107.18-37.22-37.88-23.69
Net Income
-67.66-67.66-99.13-129.42-66.84
Earnings Per Share
-0.10-0.10-0.21-0.28-0.15
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
58.3558.3534.8660.1579.11
Total Debt
0.760.76386.71323110.8
Net Cash (Debt)
57.5957.59-351.84-262.85-31.69
Net Cash Growth
-----
Net Cash Per Share
0.090.09-0.74-0.57-0.07

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-51.54-51.54-26.52-22.51-20.05
Capital Expenditures
-0.2-0.2-0.16-0.56-0.78
Free Cash Flow
-51.74-51.74-26.68-23.06-20.83
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-42363.24%-42363.24%-364.43%-4304.20%-5029.09%
Pretax Margin
-26788.14%-26788.14%-962.38%-14703.98%-14173.25%
Profit Margin
-26743.08%-26743.08%-970.53%-14706.59%-14190.66%
FCF Margin
-20449.01%-20449.01%-261.18%-2620.68%-4422.08%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
501.802215.23---